Member Info for ihalliwell10

I'm tempted to add to my 2021 holding to, I must admit these are getting pretty much everything right thus far, I think 2022 could be a bigger year than 2021 at this rate, well backed by IIs to fund the next stage this year, a real contender for another doubling in size this year, with further acquisitions.

I think we will see £1.20 fairly soon, and with news beyond, best and simple thing about SRC is that with each acquisition they can tweak numbers to show growth without anything organic going on, with organic growth (which I think the EU/UK is going through in build/construction) as well, means this is a double bagger for me.

DYOR , considering adding to these below £1.

This looks compelling to me, in terms of a finished product that solves a real problem , most importantly its easy to use and speeds up analysis both of which are key to moving quickly to get ideas into vaccines at pace.....

https://lablogic.com/life-sciences/instruments/phasefocus-livecyte

DYOR

This could represent my first ever triple purchase of a stock on the way up.

DYOR

The Group is also currently working with several major contractors on significant commercial and infrastructure projects.

Seems to me that the II's got a bargain in this at circa 80p, nothing here to suggest that SRC is on its way to continued growth, I wonder if there is an even bigger acquisition in the 2nd half of 2022, with Goldman on board raising money shouldn't be a problem, I also think that raising cash through a placing will be coming to fund the next stage ( hope us small investors are included).

DYOR , this will be £1 by Jan and continue from there.

I'm thinking the same, 30% upside from here

https://twitter.com/Dorothy_Perkins/status/1469346742143438848?t=vuaLeVE239iFsTmIaPenSw&s=19

Sales or returns going well, either way DP seems to be trading well.

CNBC stating a large amount of call options , which I think it IIs loading up to bake in the 6% Divi and potential 36 month growth story here.

Could be the start of the begining for VOD

I guess it's 25M to buy it all now as unproven (other than in a lab setting) verses 200M proven and allowed to be used everywhere

Thought Amigo was less risky than this tbh,

probably as I sold for a 50% profit two weeks ago , GLA

logistics and house sales slow down the next tail winds, but they may be unfounded for bree..... wonder where this ends up in terms of share price, I'm considering of reducing around 119p in the short term

DYOR

un trade-able on II,

looks like leaky leak is coming,

a complete guy based upon 50M new group size....., probably get to this around march next year

think its due to the supplier concerns , i.e. getting product to the site / customer, but thats a short term problem for me, holding on tight, still see this a double bagger from here over a 2 year period.

Interesting development , if this was in the US it would rocket , over here in the UK it will be down to fundamentals therefore probably come back at the same or lower price , but a nice deal nevertheless.

DYOR

re reading the resutls, I think they state that basically they have 4.6M in cash in the bank, plus access to 30 odd mill is debt facility , it doesn't state if this is drawn or not.

This interesting statement for me is the

Net bank debt reduced from £22.0 million at the end of FY20 to £3.6 million at the end of FY21, and today the Group has cash in bank less all drawings on the RCF and CLBILS ("net cash") of £4.6 million

Meaning that we have gone from -3.6M to +4.6M from end of FY21 to now. It that carries on then there could be bumper numbers over the short term.

I think because some of the good news is actually through debt facilities and the amount of cash banked is lower than previously reported

Share dilution probably means 35/40p in last year's share price .

Still way above where we are

DYOR

holding for 35p, cash is pouring in only a lockdown could de rail these,

DYOR

Just needs traction and sales now,

DYOR